Dehydroepiandrosterone: An unknown star;DHEA: Célèbre et méconnue

Revue de Medecine Interne

Volumn 23, Issue 5, 2002, Pages 436-446

  Schlienger, J L ^a   Perrin, A E ^a   Goichot, B ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Adrenal insufficiency; Aging; Clinical trial; DHEA; Post menopausal; S DHEA

Indexed keywords

INSULIN; NEUROSTEROID; PRASTERONE; PRASTERONE SULFATE;

ADRENAL INSUFFICIENCY; AGING; ANTIINFLAMMATORY ACTIVITY; CANCER RISK; CARDIOVASCULAR RISK; COGNITION; DYSTHYMIA; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; IMMUNOMODULATION; INSULIN RESISTANCE; MENOPAUSE; METABOLIC DISORDER; NEUROPSYCHIATRY; NONHUMAN; OBESITY; PROSPECTIVE STUDY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; WELLBEING;

EID: 0036099827     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00591-X     Document Type: Short Survey

References (86)

1. Dehydroepiandrosterone (DHEA): A fountain of youth?
2. Dehydroepiandrosterone (DHEA), DHEA sulfate and aging: Contribution of the DHEAge study to a sociobio-medical issue
3. DHEA deficiency syndrom: A new term for old age?
4. DHEA: A hormone with multiple effects
5. Uber androsten, einkystallisiertes männliches sexual hormon
6. Identification and isolation of dehydroepiandrosterone from peripheral human plasma
7. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex, day to day and diurnal variations
8. Physiological changes in DHEA are not reflected by the serum levels of active androgens and estrogens but of their metabolites: Intracrinology
9. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissus: Its role during aging
10. Dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3β hydroxy steroid dehydrogenase
11. Physiological importance of dehydroepiandrosterone
12. DHEA and DHEA-S: A review
13. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentration throughout adult hood
14. Differential changes in serum concentrations of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness
15. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting
16. Dehydroepiandrosterone replacement therapy
17. Dehydroepiandrosterone: Kinetics of metabolism in normal men and women
18. Opposite effects of dehydroepiandrosterone on the growth of 7, 12 dimetlylbenz-anthracene-induced rat mammary carcinomas
19. Metabolic effects of 12-month percutaneous DHEA replacement therapy in post menopausal women
20. Dehydroepiandrosterone replacement administration: Pharmaco-kinetic and pharmacodynamic studies in healthy elderly subjects
21. The role of androgen in women
22. The effects of dehydroepintandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters and health-related quality of life
23. Androgen deficiency in women
24. Which androgen replacement therapy for women?
25. Effect of 12-month DHEA replacement therapy on bone, vaginum, and endometrium in postmenopausal women
26. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breat cancer
27. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7, 12-dimethyl benzanthracene in the rat
28. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone
29. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: Prospective results from the massachusets Male Aging Study
30. Dehydroepiandrosterone improves cardiovascular function in mechanisms independent of androgen and estrogen receptors: In vitro and in vivo studies
31. Hormonal changes in aging men: A therapeutic indication?
32. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men
33. Replacement of DHEA in aging men and women. Potential remedial effects
34. Dehydroepiandrosterone replacement in aging humans
35. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
36. The effects of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women
37. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo study
38. Relationships among cortisol, dehydroepiandrosterone sulfate and memory in a longitudinal study of healthy elderly men and women
39. Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being
40. A prospective study on cortisol, dehydroepiandrosterone sulfate and cognitive function in the elderly
41. Increase in urinary control excretion and memory declines: Mac Arthur studies of successful aging
42. Salivary cortisol and DHEA: Association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation
43. Dehydroepiandrosterone (DHEA) supplementation for cognitive function
44. Effet de l'administration de la DHEA sur les propriétés vasculaires des hommes de plus de 70 ans: Résultats de l'étude DHEAge
45. DHEA-PC slows the progression of type 2 diabetes (non insulin dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat
46. The effects of DHEA given chronically to Zucker rats
47. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats
48. Obesity in the dog: Role of the adrenal dehydroepiandrosterone (DHEA)
49. On the mechanism of interaction of steroids with human glucose-6-phospate dehydrogenase
50. Therapeutic effects of dehydroepiandrosterone (DHEA) on diabetic mice
51. Reduction of atherosclerosis by administration of dehydroepiandrosterone
52. Antiglucocorticoid effects of dehydroepiandrosterone (DHEA)
53. Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats
54. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence
55. Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone
56. Dehydroepiandrosterone antagonizes the suppressive effect of dexamethasone on lymphocyte proliferation
57. Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs
58. DHEA: A novel adjunct for the treatment of male trauma patients
59. Neurosteroids: Deficient cognitive performance in aged rats depends on low pregnenole sulfate levels in the hippocampus
60. Dehydroepidansterone replacement in women with adrenal insufficiency
61. Improvement in mood and fatigue after dehydroepiandrosterone replacement an Addison's disease in a randomised, double-blind trial
62. Dehydroepinandrosterone replacement for patient with adrenal insufficiency
63. Control levels during human aging predict hippocampal atrophy and memory deficits
64. Dehydroepiandrosterone protects hippocampal neurons against neuro-toxin-induced cell death: Mechanism of action
65. Dehydroepiandrosterone: A neurosteroid
66. Dehydroepiandrosterone (DHEA) and DHEA-S as neuroactive neurosteroids
67. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures
68. Effects of a two week physiologicol dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men
69. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study
70. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associeted with depressed mood in older women: The Rancho Bernardo Study
71. Dehydroepiandrosterone treatment of midlife dysthymia
72. DHEA treatment for HIV + patients: Effects on mood, androgenic and anabolic parameters
73. Double-blind treatment of major depression with dehydroepiandrosterone
74. Dehydroepiandrosterone in the treatment of erectile dysfunction: A prospective, double-blind, randomized, placebo-controlled study
75. A prospective study of dehydroepiandrosterone sulfate, mortality and cardivascular disease
76. Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in post menopausal women
77. Dehydroepiandrosterone sulfate and mortality in elderly men and women
78. Lack of effect of dehydroepiandrosterone in obese men
79. Abnormal 24-hr mean plasma concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate in women with primary operable breast cancer
80. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial
81. A double-blind placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus
82. Level of sex hormone binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes
83. Decreased testosterone and dehydroepiandrostenedione sulfate concentrations are associated with increased insulin and glucose concentation in non diabetic men
84. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men
85. Liquid chromatographic determina tion of dehydroepiandrosterone in dietary supplements product